Metropolitan Life Insurance Company (MetLife)’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,869
| Closed | -$98.7K | – | 1690 |
|
|
2024
Q1 | $98.7K | Hold |
3,869
| – | – | ﹤0.01% | 1058 |
|
|
2023
Q4 | $35K | Hold |
3,869
| – | – | ﹤0.01% | 1631 |
|
|
2023
Q3 | $24.7K | Hold |
3,869
| – | – | ﹤0.01% | 1791 |
|
|
2023
Q2 | $42.9K | Buy |
3,869
+338
| +10% | +$3.75K | ﹤0.01% | 1507 |
|
|
2023
Q1 | $54.2K | Buy |
3,531
+220
| +7% | +$3.38K | ﹤0.01% | 1342 |
|
|
2022
Q4 | $73.5K | Buy |
3,311
+339
| +11% | +$7.52K | ﹤0.01% | 1236 |
|
|
2022
Q3 | $48.5K | Hold |
2,972
| – | – | ﹤0.01% | 1476 |
|
|
2022
Q2 | $43.2K | Buy |
2,972
+764
| +35% | +$11.1K | ﹤0.01% | 1596 |
|
|
2022
Q1 | $40.8K | Sell |
2,208
-7,161
| -76% | -$132K | ﹤0.01% | 1712 |
|
|
2021
Q4 | $223K | Hold |
9,369
| – | – | ﹤0.01% | 1955 |
|
|
2021
Q3 | $231K | Hold |
9,369
| – | – | ﹤0.01% | 1958 |
|
|
2021
Q2 | $232K | Buy |
9,369
+421
| +5% | +$10.4K | ﹤0.01% | 2040 |
|
|
2021
Q1 | $195K | Buy |
8,948
+3,871
| +76% | +$84.4K | ﹤0.01% | 2035 |
|
|
2020
Q4 | $130K | Hold |
5,077
| – | – | ﹤0.01% | 2219 |
|
|
2020
Q3 | $143K | Buy |
+5,077
| New | +$143K | ﹤0.01% | 1998 |
|